Influence of ABCB1 genetic variants in breast cancer treatment outcomes

Evans, 1999, Pharmacogenomics: translating functional genomics into rational therapeutics, Science, 286, 487, 10.1126/science.286.5439.487 Rodrigues, 2008, Correlation of polymorphism C3435T of the MDR-1 gene and the response of primary chemotherapy in women with locally advanced breast cancer, Genet Mol Res, 7, 177, 10.4238/vol7-1gmr400 Evans, 2003, Pharmacogenomics – drug disposition, drug targets, and side effects, N Engl J Med, 348, 538, 10.1056/NEJMra020526 Gottesman, 2002, Multidrug resistance in cancer: role of ATP dependent transporters, Nat Rev Cancer, 2, 48, 10.1038/nrc706 Burger, 2003, RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response, Clin Cancer Res, 9, 827 Mutoh, 2006, Estrogen mediated post transcriptional down-regulation of P-glycoprotein in MDR1-transduced human breast cancer cells, Cancer Sci, 97, 1198, 10.1111/j.1349-7006.2006.00300.x Chen, 1990, Genomic organization of the human multidrug resistance (MDR1) gene and origin of P-glycoproteins, J Biol Chem, 265, 506, 10.1016/S0021-9258(19)40260-3 Fojo, 1986, Localization of multidrug resistance-associated DNA sequences to human chromosome 7, Somat Cell Mol Genet, 12, 415, 10.1007/BF01570737 Kim, 2001, Identification of functionally variant MDR1 alleles among European Americans and African Americans, Clin Pharmacol Ther, 70, 189, 10.1067/mcp.2001.117412 Cascorbi, 2001, Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR gene in white subjects, Clin Pharmacol Ther, 69, 169, 10.1067/mcp.2001.114164 Kafka, 2003, Polymorphism C3435T of the MDR-1 gene predicts response to preoperative chemotherapy in locally advanced breast cancer, Int J Oncol, 22, 1117 Cizmarikova, 2010, MDR1 (C3435T) polymorphism: relation to the risk of breast cancer and therapeutic outcome, Pharmacogenomics J, 10, 62, 10.1038/tpj.2009.41 Zhang, 2011, Polymorphisms of GSTP1 is associated with differences of chemotherapy response and toxicity in breast cancer, Chin Med J (Engl), 124, 199 Tsai, 2009, Side effects after docetaxel treatment in Taiwanese breast cancer patients with CYP3A4, CYP3A5, and ABCB1 gene polymorphisms, Clin Chim Acta, 404, 160, 10.1016/j.cca.2009.03.038 Therasse, 2000, New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada, J Natl Cancer Inst, 92, 205, 10.1093/jnci/92.3.205 Cancer Therapy Evaluation Program, 2003 Miller, 1988, A simple salting out procedure for extracting DNA from human nucleated cells, Nucleic Acids Res, 16, 1215, 10.1093/nar/16.3.1215 Hamdy, 2003, Genotype and allele frequencies of TPMT, NAT2, GST, SULT1A1 and MDR-1 in the Egyptian population, Br J Clin Pharmacol, 55, 560, 10.1046/j.1365-2125.2003.01786.x Gauderman, 2002, Sample size requirements for matched case–control studies of gene–environment interaction, Stat Med, 21, 35, 10.1002/sim.973 Cochran, 1954, The combination of estimates from different experiments, Biometrics, 10, 101, 10.2307/3001666 Higgins, 2002, Quantifying heterogeneity in a meta-analysis, Stat Med, 21, 1539, 10.1002/sim.1186 Egger, 1997, Bias in meta-analysis detected by a simple, graphical test, BMJ, 315, 629, 10.1136/bmj.315.7109.629 Chang, 2009, Association of the ABCB1 gene polymorphisms 2677G>T/A and 3435C>T with clinical outcomes of paclitaxel monotherapy in metastatic breast cancer patients, Ann Oncol, 20, 272, 10.1093/annonc/mdn624 George, 2009, A single-nucleotide polymorphism in the MDR1 gene as a predictor of response to neoadjuvant chemotherapy in breast cancer, Clin Breast Cancer, 9, 161, 10.3816/CBC.2009.n.026 Leonessa, 2003, ATP binding cassette transporters and drug resistance in breast cancer, Endocr Relat Cancer, 10, 43, 10.1677/erc.0.0100043 Ji, 2012, Polymorphisms in genes involved in drug detoxification and clinical outcomes of anthracycline-based neoadjuvant chemotherapy in Chinese Han breast cancer patients, Cancer Biol Ther, 13, 264, 10.4161/cbt.18920